LK

Leela Kanwar

Active Director Director DIN 07110887
DIN 07110887 First appointment Jun 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since Jun 2015
Shareholding value •••• Premium profile

About Leela Kanwar

Data last updated:

Leela Kanwar is a Director at Trust Chemists And Druggists Private Limited (since 2018), Director at Lyrus Life Sciences Private Limited (since 2015) and Partner at Nokha Trading Llp (since 2015), and holds 3 more current directorships. The companies operate in Pharma, Business Services and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹286 Cr; the largest is Trust Chemists And Druggists Private Limited at ₹204 Cr (FY 2025). Earlier, Leela Kanwar was a Director at H K Technologies Limited (2016–2017).

DIN 07110887
Primary Designation Director
Industry Pharma
First Appointment 16 Jun 2015
Oldest Company Age 23 yrs
Largest company Trust Chemists And Druggists Private Limited · ₹204 Cr (FY 2025)
Combined revenue ₹286 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Sep 20182003₹204 Cr (FY 2025)Active
Lyrus Life Sciences Private Limited U24230KA2015PTC080902
Director16 Jun 20152015₹60.95 Cr (FY 2025)Active
Partner21 Dec 20152015₹17.26 Cr (FY 2023)Active
Qp Health Services Limited U24232KA2008PLC048461
Director03 Sep 20182008₹4.44 Cr (FY 2025)Active
Partner06 Jan 20242024Active
Designated Partner24 Aug 20172017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
H K Technologies Limited U51397KA1993PLC014466
Director01 Apr 20161993₹2.03 Cr (FY 2016)Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Leela Kanwar

Directorship timeline

Open interactive timeline →
Lyrus Life Sciences Private Limited
Qp Health Services Limited
Trust Chemists And Druggists Private Limited
Nokha Life Sciences Llp
Premium access

Shareholding and investment profile for Leela Kanwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Leela Kanwar

Leela Kanwar currently holds 6 directorships: Trust Chemists And Druggists Private Limited (Director, since 01 Sep 2018, revenue ₹204 Cr (FY 2025)); Lyrus Life Sciences Private Limited (Director, since 16 Jun 2015, revenue ₹60.95 Cr (FY 2025)); Nokha Trading Llp (Partner, since 21 Dec 2015, revenue ₹17.26 Cr (FY 2023)); Qp Health Services Limited (Director, since 03 Sep 2018, revenue ₹4.44 Cr (FY 2025)); Equidor Medtech Llp (Partner, since 06 Jan 2024); and 1 more.

Leela Kanwar was first appointed on 16 Jun 2015 as Director at Lyrus Life Sciences Private Limited. The most recent appointment on record is 06 Jan 2024 at Equidor Medtech Llp.

The 4 current companies of Leela Kanwar that report revenue have a combined latest revenue of ₹286 Cr: Trust Chemists And Druggists Private Limited ₹204 Cr (FY 2025); Lyrus Life Sciences Private Limited ₹60.95 Cr (FY 2025); Nokha Trading Llp ₹17.26 Cr (FY 2023); Qp Health Services Limited ₹4.44 Cr (FY 2025).

Leela Kanwar held 1 earlier board appointment: H K Technologies Limited (Director, 01 Apr 2016 to 27 Mar 2017).

The current boards of Leela Kanwar's companies include Dinyar Dhun Elavia (Trust Chemists And Druggists Private Limited), Hemanth Kumar Bothra (Trust Chemists And Druggists Private Limited), Dasari Ramesh (Lyrus Life Sciences Private Limited), Chandanmal Pukhraj Bothra (Nokha Trading Llp), Chillale Govindaraj (Qp Health Services Limited), Anagha Anilkumar Katti (Equidor Medtech Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available